Merck’s Hyzaar Approved For Stroke Prevention
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approval is based on results of the LIFE outcomes study; Cozaar was approved for same indication in March 2003. Like Cozaar, the benefit of Hyzaar in stroke prevention does not appear to be applicable to black patients, labeling says.